No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
314 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) labii (oris)
Melanocytic naevi of lip
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2143 | 1358 | 781 |
| Only index persons | 2030 | 1302 | 728 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 39.45 | 40.56 | 37.57 |
| Only index persons | 38.35 | 40.23 | 35.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 314 | 237 | 77 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.03 |
| Median age at first event (years) | 43.83 | 42.12 | 49.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 291
- Matched controls
- 2911
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D22.0
ICD-10 Finland
Melanocytic naevi of lip
11619.1
323.0
264
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.8
31.9
73
106
2160A
ICD-9 Finland
Benign neoplasm of skin, Skin of lip[HUULEN IHON BENIGNI KASVAIN,NAEVUS PIGMENTOSUS]
+∞
28.6
27
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
8.0
20.5
48
70
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
27.6
17.2
23
9
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.2
13.5
43
94
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
5.5
12.7
38
77
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
12.3
50
140
EAA10
NOMESCO Finland
Excision of lesion of lip
15.7
9.6
15
10
9733
FHL
Excision of skin change in operating room or anesthesia
11.2
9.4
17
16
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
7.7
9.4
21
29
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.7
8.7
29
67
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
7.0
7.7
18
27
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.6
6.9
19
36
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
55
302
2.00
4.74
3.1
2.2
%
23.8
22.6
0.25
48
263
(40768804) Tissue Pathology biopsy report
141
1050
1.62
4.22
2.5
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
98
675
1.66
3.96
3.1
2.9
mmol/l
6.7
7.4
0.70
80
570
(3012516) Albumin [Mass/volume] in Urine
88
604
1.63
3.56
3.2
3.1
mg/l
2351.4
158.7
0.99
53
385
(3020682) Albumin/Creatinine [Ratio] in Urine
92
645
1.60
3.40
3.9
3.9
mg/mmol
9.3
7.5
0.14
57
395
(42870588) Differential panel, method unspecified - Blood
110
811
1.55
3.25
5.4
5.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
6
8.44
2.76
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.44
2.76
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
119
920
1.47
2.72
2.0
1.9
pmol/l
98.4
95.6
0.23
54
458
(3024561) Albumin [Mass/volume] in Serum or Plasma
128
1009
1.45
2.63
3.7
4.1
g/l
36.8
36.1
0.71
122
946
(3013115) Eosinophils [#/volume] in Blood
160
1321
1.43
2.53
6.3
5.6
e9/l
0.2
0.2
1.03
140
1168
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
45
2.73
2.48
1.2
1.1
u/ml
0.1
1.5
—
7
15
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
125
2.00
2.43
1.5
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
54
360
1.60
2.42
2.7
2.8
e6/l
2.1
3.0
0.48
24
189
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
8
6.33
2.38
1.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
222
1966
1.44
2.26
4.1
3.9
mm/h
12.2
10.9
0.59
208
1820
(3001604) Monocytes [#/volume] in Blood
153
1273
1.39
2.22
6.4
5.3
e9/l
0.5
0.5
0.54
130
1108
(3037467) Urinalysis macro (dipstick) panel - Urine
204
1783
1.41
2.21
4.6
4.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
78
1021
0.69
2.19
3.1
2.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
41
262
1.65
2.17
2.3
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
153
1278
1.38
2.15
6.3
5.3
e9/l
0.0
0.0
0.46
131
1114
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
43
280
1.62
2.12
1.7
2.6
umol/l
7.1
7.6
0.11
37
235
(1617658) Protocol used for examination of sentinel lymph nodes
9
31
2.96
2.09
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
8
26
3.13
2.02
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
166
1.75
1.95
1.1
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
107
856
1.38
1.91
3.4
3.0
u/l
30.4
29.4
0.19
100
823
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
78
592
1.42
1.89
2.3
2.0
mg/l
2.8
3.1
0.58
67
505
(3019198) Lymphocytes [#/volume] in Blood
154
1308
1.35
1.87
6.4
5.4
e9/l
2.0
2.0
0.07
138
1165
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
13
3.89
1.72
2.6
2.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
19
104
1.88
1.71
1.5
1.5
miu/ml
196.9
245.8
0.31
11
57
(3022096) Basophils/100 leukocytes in Blood
137
1155
1.33
1.70
6.7
5.4
%
0.7
0.7
0.22
126
1069
(3019550) Sodium [Moles/volume] in Serum or Plasma
277
2604
1.54
1.69
16.5
13.6
mmol/l
139.4
139.7
1.09
270
2527
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
227
2066
1.36
1.62
4.5
4.1
pmol/l
14.5
14.6
0.14
208
1900
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
385
1.45
1.62
2.5
2.6
e6/l
0.8
0.9
0.11
23
214
(3013650) Neutrophils [#/volume] in Blood by Automated count
172
1507
1.31
1.59
9.8
8.7
e9/l
4.2
4.0
0.34
149
1322
(3002256) Pathology report gross observation
45
318
1.48
1.58
1.5
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
57
2.15
1.57
1.2
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
15
3.37
1.53
2.0
6.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
50
366
1.44
1.47
1.6
1.4
titre
250.0
511.6
1.83
12
90
(3023103) Potassium [Moles/volume] in Serum or Plasma
276
2610
1.47
1.44
17.2
13.7
mmol/l
3.9
3.9
0.05
270
2531
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
261
2444
1.40
1.44
5.6
4.8
mu/l
1.9
2.3
0.42
246
2252
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
88
1.86
1.44
1.3
2.0
g/l
6.9
7.6
—
10
70
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
88
1.86
1.44
1.3
2.0
g/l
3.4
3.8
—
10
67
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
88
1.86
1.44
1.3
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
74
1.93
1.41
1.6
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
112
1.74
1.39
5.7
12.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
82
1.87
1.38
1.2
2.1
g/l
3.1
3.3
—
10
67
(40768793) Breast Pathology biopsy report
15
82
1.87
1.38
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
217
1.53
1.37
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
554
1.34
1.31
3.0
3.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
23
146
1.62
1.30
2.9
2.7
e9/l
66.1
69.0
0.21
15
112
(44813793)
5
18
2.81
1.29
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
115
1.69
1.28
3.4
2.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
35
2.32
1.27
1.1
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
151
1327
1.27
1.27
5.5
5.5
umol/l
12.3
10.4
0.88
145
1261
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
307
1.42
1.26
2.1
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
53
404
1.38
1.25
1.6
1.7
nmol/l
1398.5
1244.3
0.32
44
293
(3001122) Ferritin [Mass/volume] in Serum or Plasma
140
1221
1.26
1.25
3.4
2.7
ug/l
103.9
90.4
0.48
135
1134
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
19
2.66
1.22
1.4
1.2
—
94.4
—
0
5
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
124
1069
1.26
1.21
2.2
2.3
nmol/l
80.2
76.6
0.95
113
964
(3006504) Eosinophils/100 leukocytes in Blood
138
1205
1.26
1.21
6.7
5.3
%
3.2
2.7
1.07
127
1118
(3023323) Follitropin [Units/volume] in Serum or Plasma
22
141
1.60
1.21
1.2
1.3
iu/l
27.0
27.5
0.02
22
120
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
38
2.13
1.19
2.4
1.9
%
13.8
13.2
—
8
38
(3038026) Centromere Ab [Units/volume] in Serum
5
20
2.52
1.15
1.4
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
138
1211
1.25
1.15
6.8
5.6
%
8.2
8.3
0.13
128
1133
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
213
1963
1.26
1.14
7.6
6.9
u/l
76.3
76.7
0.05
199
1845
(3026008) Bacteria identified in Urine by Culture
91
761
1.28
1.14
3.4
2.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
493
1.32
1.12
1.3
1.3
u/ml
1.3
10.6
3.42
30
191
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
7
31
2.29
1.11
1.3
1.3
pmol/l
518.7
339.2
—
7
25
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
442
1.32
1.07
3.3
3.0
ng/l
410.6
154.5
0.64
40
307
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
52
1.95
1.07
1.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
139
1228
1.24
1.07
6.7
5.9
mmol/l
1.2
1.2
0.33
119
1019
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
107
0.46
1.03
1.2
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
287
2765
1.44
1.02
11.5
9.5
u/l
25.8
25.0
0.45
279
2680
(40768797) Stomach Pathology biopsy report
44
338
1.35
1.01
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
76
1.74
1.00
4.0
3.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
116
1.59
0.99
1.8
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
208
1.43
0.99
2.6
2.6
ml/min/173m2
68.5
69.2
0.03
12
80
(3018010) Neutrophils/100 leukocytes in Blood
137
1221
1.22
0.94
6.5
5.3
%
58.0
56.6
0.83
127
1141
(3002030) Lymphocytes/100 leukocytes in Blood
139
1241
1.22
0.94
6.7
5.4
%
28.5
28.8
0.12
128
1157
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
27
2.25
0.94
1.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
41
317
1.34
0.91
2.4
2.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
299
2912
1.56
0.90
23.9
18.3
e9/l
259.9
255.9
0.53
294
2846
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
29
2.09
0.90
1.0
1.2
nmol/l
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
79
1.67
0.89
1.4
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
92
792
1.23
0.88
2.0
2.3
u/l
53.4
54.9
0.21
86
736
(3002385) Erythrocyte distribution width [Ratio]
239
2259
1.24
0.88
20.0
15.1
%
13.7
13.6
0.23
234
2225
(3001019) Free T4 and TSH panel - Serum or Plasma
10
167
0.59
0.87
2.0
1.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
299
2914
1.55
0.86
23.8
18.2
pg
30.1
30.2
0.41
294
2873
(3024731) MCV [Entitic volume]
299
2914
1.55
0.86
23.8
18.2
fl
90.4
90.7
0.50
294
2873
(40761511) CBC panel - Blood by Automated count
285
2755
1.37
0.86
16.0
11.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
96
1.59
0.86
2.5
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
299
2915
1.54
0.85
23.9
18.3
e12/l
4.5
4.5
0.20
293
2844
(3021788) Differential panel - Synovial fluid
6
31
1.95
0.85
2.3
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
299
2916
1.53
0.83
23.9
18.3
e9/l
6.8
6.7
0.58
293
2843
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
626
1.24
0.83
2.6
3.0
ng/l
2962.5
1149.8
0.40
63
530
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
97
1.57
0.83
1.3
1.6
—
10.1
—
0
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
404
1.28
0.83
1.9
2.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
299
2917
1.52
0.82
24.0
18.4
g/l
133.6
134.5
0.59
294
2876
(3003396) Base excess in Arterial blood by calculation
33
252
1.35
0.81
4.7
8.4
mmol/l
1.5
1.3
0.07
23
203
(40768800) Prostate Pathology biopsy report
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
34
262
1.33
0.79
3.4
3.9
ug/l
2.2
50.4
0.93
29
214
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
27
0.00
0.78
0.0
18.8
—
7.0
—
0
19
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
244
2323
1.23
0.77
6.0
5.2
mmol/mol
39.3
39.2
0.09
224
2178
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
116
1.49
0.76
1.5
1.4
—
—
—
0
0
(4010399)
24
176
1.39
0.75
1.7
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
364
1.28
0.74
2.0
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
182
0.65
0.73
3.2
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
84
1.57
0.73
1.3
1.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
39
1.81
0.73
1.6
3.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
320
1.29
0.72
1.7
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
273
2636
1.27
0.72
14.8
12.2
mg/l
18.3
21.1
1.12
208
2046
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
496
1.23
0.71
1.2
1.3
iu/ml
38.1
27.4
0.21
18
160
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
19
135
1.43
0.71
3.8
7.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
61
1.66
0.69
1.5
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
32
250
1.31
0.69
4.8
8.4
kpa
12.4
12.8
0.12
27
242
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
32
250
1.31
0.69
4.8
8.4
kpa
5.4
5.2
0.24
27
242
(3023419) Bacteria identified in Sputum by Culture
5
27
1.87
0.68
3.2
2.4
—
—
—
0
0
(4281824)
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
100
891
1.18
0.66
3.9
3.6
e6/l
114.0
74.8
0.29
64
614
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
27
207
1.33
0.66
1.3
2.4
g/l
0.2
0.2
0.19
27
193
(3021960) Folate [Moles/volume] in Serum or Plasma
65
557
1.21
0.66
1.5
1.5
nmol/l
21.5
21.7
0.03
57
462
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
257
2472
1.22
0.65
4.8
4.1
mmol/l
5.7
5.8
0.87
239
2275
(3044889) 12 lead EKG panel
187
1752
1.17
0.65
3.8
3.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
56
473
1.22
0.65
1.8
1.7
pmol/l
496.9
30904971.9
0.78
48
398
(3030467) Casts [#/volume] in Urine by Automated count
77
672
1.19
0.64
3.3
2.9
e6/l
0.8
0.4
0.75
52
506
(3026782) Osmolality of Urine
57
483
1.22
0.64
4.1
2.5
mosm/kgh2o
547.0
546.5
0.00
45
414
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
31
245
1.29
0.62
2.3
2.2
u/l
32.0
28.8
0.48
24
209
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
49
1.65
0.62
2.1
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
198
0.69
0.62
1.8
1.4
—
—
—
0
0
(3012544) pH of Venous blood
26
201
1.32
0.61
3.7
2.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
81
714
1.18
0.61
2.2
2.0
u/l
226.4
242.3
0.05
76
678
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
20
0.00
0.60
0.0
1.2
—
1.1
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
1.2
—
0
13
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
129
1182
1.16
0.59
11.6
8.6
e9/l
0.0
0.0
0.39
99
981
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
132
1212
1.15
0.59
5.0
3.9
—
—
—
0
0
(4035726)
27
212
1.30
0.58
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
28
350
0.78
0.57
1.7
2.3
ug/g
61.2
122.8
1.76
19
271
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
54
1.49
0.57
2.3
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
36
294
1.25
0.57
5.0
4.1
%
20.2
22.2
0.44
20
126
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
(3013512) EKG study
77
680
1.18
0.57
3.7
3.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
55
1.47
0.56
1.1
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
79
886
0.86
0.56
2.9
3.4
ng/l
26.2
70.5
0.52
46
567
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
75
662
1.17
0.56
1.3
1.2
u/ml
0.6
2.0
1.25
19
179
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
61
1.49
0.54
2.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
121
1112
1.14
0.52
5.8
5.3
mmol/l
1.2
1.2
0.17
109
1011
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
187
1769
1.14
0.52
3.0
2.8
u/l
47.1
40.4
0.57
178
1670
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
40
1.51
0.52
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
40
1.51
0.52
1.2
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
40
1.51
0.52
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
67
590
1.17
0.51
1.4
1.3
g/l
2.1
2.2
0.23
39
354
(3037121) Protein [Mass/volume] in Urine
11
75
1.48
0.51
1.5
3.4
g/l
0.3
0.2
—
6
23
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
136
1.34
0.50
1.6
2.2
u/l
9155.7
2269.2
—
5
51
(3037756) Immunofixation for Serum or Plasma
7
46
1.53
0.48
1.3
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
165
0.72
0.47
2.1
2.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
111
1.37
0.47
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
111
1.37
0.47
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
137
1277
1.13
0.47
3.6
3.5
estimate
0.0
0.0
0.00
26
267
(3002582) Erythrocytes [#/volume] in Urine
82
739
1.15
0.47
3.5
3.0
e6/l
48.6
133.5
0.45
58
568
(3009542) Hematocrit [Volume Fraction] of Blood
249
2411
1.16
0.46
16.7
13.3
%
39.3
39.9
0.50
181
1846
(40768443) Skin Pathology biopsy report
14
103
1.38
0.46
1.4
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
112
1.36
0.45
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
112
1.36
0.45
1.6
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
185
0.75
0.44
1.9
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
95
1.38
0.44
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
62
695
0.87
0.44
3.9
3.8
estimate
0.0
0.0
0.00
24
264
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
283
0.80
0.43
2.0
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
31
1.62
0.43
4.0
2.3
mmol/l
102.0
106.0
—
5
31
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
31
1.62
0.43
4.0
2.3
mmol/l
4.0
4.0
—
5
31
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
31
1.62
0.43
4.0
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
109
1007
1.13
0.43
3.4
3.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
32
1.57
0.42
1.2
1.4
%
68.0
59.8
—
5
32
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
34.7
—
0
9
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.1
—
550245.0
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
532.1
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
260.3
—
0
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
59
1.37
0.41
1.8
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
313
0.82
0.41
1.5
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
313
0.82
0.41
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
34
1.48
0.40
1.8
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
102
0.68
0.40
1.3
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
92
845
1.13
0.40
3.1
3.1
mmol/l
2.4
2.4
0.49
85
754
(3020961) Endomysium IgA Ab [Titer] in Serum
11
148
0.73
0.39
1.1
1.1
—
106.2
—
0
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
35
1.44
0.39
1.2
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
87
799
1.12
0.38
2.2
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
72
1.40
0.37
1.1
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
443
1.15
0.37
2.3
2.7
mmol/l
2.4
2.4
0.75
38
393
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
191
1832
1.11
0.37
3.4
3.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
162
1.25
0.36
1.2
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
41
1.47
0.36
1.2
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
41
1.47
0.36
1.2
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
144
1.27
0.36
1.3
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
30
350
0.84
0.35
1.7
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
136
1285
1.10
0.35
5.3
4.8
estimate
0.0
0.0
0.00
27
262
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
43
1.40
0.35
1.5
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
570
1.13
0.35
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
88
0.68
0.33
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
119
1.27
0.32
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
119
1.27
0.32
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
119
1.27
0.32
1.3
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
265
2597
1.13
0.30
5.2
4.5
mmol/l
2.7
2.8
0.75
244
2409
(3016879) Cocaine [Presence] in Urine
14
111
1.27
0.30
1.4
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
73
673
1.11
0.30
3.1
2.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
24
280
0.85
0.29
1.5
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
121
1.25
0.29
1.7
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
94
1.29
0.28
1.5
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
328
1.15
0.28
1.4
1.6
%
1.4
1.4
0.05
32
291
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
76
1.33
0.28
1.1
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
72
666
1.11
0.28
8.0
7.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
71
766
0.91
0.28
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
215
1.18
0.27
3.2
2.8
ug/l
0.7
0.8
0.26
16
131
(3009261) Glucose [Presence] in Urine by Test strip
136
1298
1.08
0.27
3.7
3.6
estimate
0.0
0.0
0.50
25
254
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
95
1.27
0.26
1.6
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
72
1.26
0.26
2.4
2.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
76
1.19
0.25
1.2
1.3
—
3.2
—
0
11
(4034850)
9
76
1.19
0.25
9.7
9.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
77
1.17
0.24
1.2
1.3
—
3.3
—
0
15
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
201
0.84
0.24
1.6
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
81
0.74
0.24
1.3
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
85
0.70
0.24
1.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
97
1.25
0.23
1.6
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
125
1.21
0.23
6.0
3.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.2
—
113.9
—
0
7
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
41
1.22
0.22
1.2
2.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
249
2445
1.09
0.22
4.1
3.7
mmol/l
1.3
1.2
0.46
227
2257
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
8.2
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
4.3
—
222.5
—
0
11
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
279
1.12
0.20
7.3
6.4
—
—
—
0
0
(3020891) Body temperature
11
90
1.23
0.19
5.8
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
242
1.13
0.19
2.1
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
148
1433
1.06
0.18
3.8
4.4
mmol/l
6.8
6.5
0.71
129
1306
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
690
1.08
0.18
1.7
1.6
mmol/l
1.3
1.4
0.58
61
589
(3019150) Specific gravity of Urine by Refractometry
58
543
1.08
0.18
3.8
3.8
kg/l
1.0
1.0
—
6
67
(3027944) Amphetamines [Presence] in Urine
14
119
1.18
0.18
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
173
0.86
0.17
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
68
1.18
0.16
9.8
3.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
63
595
1.07
0.16
2.9
2.4
umol/l
315.1
5861.5
2.54
51
515
(3002179) Metamyelocytes/100 leukocytes in Blood
21
187
1.13
0.16
9.2
3.8
%
0.0
0.7
—
5
40
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
79
0.75
0.15
1.0
1.2
u/l
9.4
12.6
—
6
63
(3000991) Gas panel - Venous blood
20
178
1.13
0.15
6.6
6.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
89
853
1.06
0.15
3.2
3.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
62
587
1.07
0.15
1.5
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
246
1.11
0.15
2.3
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
61
643
0.94
0.15
7.1
4.5
—
—
—
0
0
(1002224) Polysomnography panel
10
118
0.84
0.14
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
258
2550
1.07
0.13
4.6
4.1
mmol/l
1.5
1.5
0.00
238
2363
(40761536) Microorganisms panel - Urine sediment
21
231
0.90
0.13
2.8
3.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
96
929
1.05
0.12
12.2
7.5
inr
1.3
1.2
0.57
27
287
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
584
0.95
0.10
2.1
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
44
1.14
0.10
1.4
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
8.6
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
29
309
0.93
0.09
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
47
1.06
0.09
3.6
2.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
47
1.06
0.09
1.8
2.4
kpa
8.1
8.2
—
5
42
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
479
1.05
0.09
2.0
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
107
1.13
0.08
1.0
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
79
767
1.04
0.08
5.0
3.5
ph
7.4
7.4
0.15
12
143
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
58
1.04
0.08
2.5
1.4
—
—
—
0
0
(4094501)
5
61
0.82
0.08
1.2
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
195
1.08
0.08
9.8
4.0
%
0.1
0.2
—
8
53
(3023368) Bacteria identified in Blood by Culture
60
580
1.04
0.08
7.4
4.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
70
0.85
0.07
1.0
1.2
—
56.5
—
0
5
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
74
0.81
0.07
2.2
1.8
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
75
1.07
0.07
1.8
2.0
%
85.5
93.2
—
8
67
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
25
235
1.07
0.07
4.4
3.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
20
186
1.08
0.07
3.0
2.9
u/ml
23.0
37.5
0.90
20
178
(3022313) Gas panel - Capillary blood
7
83
0.84
0.07
1.4
2.8
—
—
—
0
0
(3036489) Thrombin time
9
88
1.02
0.07
1.7
1.9
s
20.1
21.3
—
9
74
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
258
2562
1.04
0.06
4.7
4.1
mmol/l
4.7
4.8
0.25
242
2387
(3008898) HLA-B27 [Presence]
16
148
1.09
0.06
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
245
2432
1.03
0.06
14.4
11.4
ml/min/173m2
82.8
84.6
0.62
200
1980
(3050129) First trimester maternal screen panel - Serum or Plasma
13
141
0.92
0.05
1.6
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
100
1.10
0.05
3.0
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
179
1.07
0.05
1.8
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
77
756
1.02
0.04
3.4
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
111
1.08
0.04
1.7
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
131
1.07
0.03
4.8
5.2
mmol/l
24.8
25.2
0.17
14
131
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
60
588
1.03
0.03
2.3
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
57
580
0.98
0.02
1.8
1.7
mg/l
1.1
0.9
0.31
38
441
(3025941) Bacteria identified in Stool by Culture
17
162
1.05
0.02
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
341
1.03
0.02
2.3
1.7
—
—
—
0
0
(3019225) pH of Specimen
20
207
0.96
0.01
3.9
4.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
233
1.03
0.01
1.7
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
100
1007
0.99
0.01
3.9
3.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
224
1.03
0.00
1.1
1.2
iu/ml
50.0
162.5
—
9
93
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
102
0.98
0.00
1.4
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
208
1.01
0.00
9.8
3.8
%
0.4
0.9
—
8
61
(3025159) Blasts/100 leukocytes in Blood
19
189
1.01
0.00
10.1
3.9
%
0.0
0.3
—
7
46
(42529406) Shigella sp [Presence] in Stool by Culture
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
52
517
1.01
0.00
2.8
2.5
e6/l
5.2
7.4
0.55
40
461
(3017732) Neutrophils [#/volume] in Blood
18
184
0.98
0.00
3.7
2.3
e9/l
4.1
3.8
0.35
13
153
(3000492) Spirometry study
24
236
1.02
0.00
1.6
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
284
0.98
0.00
5.1
4.3
%
32.1
32.3
0.02
18
187
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
62
0.97
0.00
1.5
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
96
0.94
0.00
1.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
4.4
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
60
1.00
0.00
2.5
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
1.4
—
0
7
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.2
—
0
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.2
—
0
7
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
11.1
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.7
—
0
5
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
14.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
78
0.90
0.00
2.3
2.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
200
1.00
0.00
1.8
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
51
0.98
0.00
1.6
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
96
0.94
0.00
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
100.3
—
0
7
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
51
0.98
0.00
1.6
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
24
240
1.00
0.00
1.3
2.1
nmol/l
391.1
379.5
0.10
24
220
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
15.1
—
0
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MELANOCYTIC_LIP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_LIP | 0.855 [0.68, 1.07] | 0.173 |
| Birth year | 1.0 [0.99, 1.01] | 0.977 |
During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 1211 females with CD2_BENIGN_MELANOCYTIC_LIP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_LIP | 1.024 [0.79, 1.32] | 0.855 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 99 out of 689 males with CD2_BENIGN_MELANOCYTIC_LIP died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MELANOCYTIC_LIP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.102% | 0.184% |
| 5 | 0.639% | 1.242% |
| 10 | 1.545% | 3.197% |
| 15 | 2.804% | 5.88% |
| 20 | 4.939% | 10.045% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_LIP – Melanocytic naevi of lip
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data